PHARMAKRYSTO

pharmakrysto-logo

PharmaKrysto's develops new treatments for people with Cystinuria, and improve their quality of life.

#SimilarOrganizations #People #Event #Website #More

PHARMAKRYSTO

Social Links:

Industry:
Biotechnology Communities Health Care Lifestyle

Website Url:
http://www.pharmakrysto.co.uk

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics WordPress Google Universal Analytics Font Awesome Wordpress Plugins Nginx Elementor


Similar Organizations

not_available_image

Anteris Bio

Anteris Bio is developing a new therapy for the treatment of renal disease.

pharmaessentia-logo

PharmaEssentia

PharmaEssentia develops treatments for myeloproliferative neoplasms, hepatitis and other diseases.

not_available_image

QualiFis

QualiFis works together with students, companies, and its clients to improve the quality of life.

not_available_image

Zenith Laboratories

Zenith Labs recognizes our responsibility to Improve the Quality of Life for our patients.

Current Employees Featured

carl-sterritt_image

Carl Sterritt
Carl Sterritt Co-founder and Chairman @ PharmaKrysto
Co-founder and Chairman
2016-01-01

julian-howell_image

Julian Howell
Julian Howell CEO @ PharmaKrysto
CEO
2018-04-01

Founder


carl-sterritt_image

Carl Sterritt

julian-howell_image

Julian Howell

Newest Events participated

bioseed_event_image Participated in BioSeed on 2019-01-16 as speaker

Official Site Inspections

http://www.pharmakrysto.co.uk Semrush global rank: 5.48 M Semrush visits lastest month: 1.56 K

  • Host name: 77.68.64.43
  • IP address: 77.68.64.43
  • Location: United Kingdom
  • Latitude: 51.4964
  • Longitude: -0.1224
  • Timezone: Europe/London

Loading ...

More informations about "PharmaKrysto"

PharmaKrysto โ€“ Transforming the lives of people with Cystinuria

PharmaKrysto is an early-stage research and development company with a mission to improve the outcomes for Cystinuria sufferers by saving kidney function and preventing unwanted pain.See details»

PharmaKrysto โ€“ Transforming the lives of people with Cystinuria

We founded PharmaKrysto to prevent pain and the risk of losing kidneys in people with Cystinuria. We have been working with a group of scientists who have discovered a method of blocking โ€ฆSee details»

PHARMAKRYSTO LTD overview - Find and update company โ€ฆ

PHARMAKRYSTO LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activitySee details»

PharmaKrysto - Crunchbase Company Profile & Funding

PharmaKrysto's develops new treatments for people with Cystinuria, and improve their quality of life.See details»

Pharmakrysto Ltd - Company Profile - Endole

Oct 23, 2017 Pharmakrysto Ltd is an active company located in Newcastle upon Tyne, Tyne and Wear. View company profile, shareholders, contacts, financials, industry and description.See details»

PHARMAKRYSTO LTD - Manufacture of basic pharmaceutical โ€ฆ

PHARMAKRYSTO LTD was founded on 2017-10-23 and has its registered office in Newcastle Upon Tyne. The organisation's status is listed as "Active". Pharmakrysto Ltd is a Private โ€ฆSee details»

PharmaKrysto Ltd. - Company Profiles - BCIQ

For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, โ€ฆSee details»

Pharmakrysto Ltd - Newcastle Upon Tyne NE12 8EG (Tyne & Wear โ€ฆ

RMT ACCOUNTANTS & BUSINESS ADVISORS LTD GOSFORTH PARK AVENUE NEWCASTLE UPON TYNE NE12 8EG United KingdomSee details»

PHARMAKRYSTO LTD - Free Company Check - CompaniesList.co.uk

PHARMAKRYSTO LTD - Free Company Check: financial information, company documents, company directors and board members, contact details, registered office, contacts ...See details»

PRESS RELEASE - PharmaKrysto

New treatment now also granted Orphan Designation in the US and EU UK, 12 July 2018. PharmaKrysto Ltd, a biopharmaceutical company based in Scotland, UK, announces today โ€ฆSee details»

PharmaKrysto - Products, Competitors, Financials, Employees ...

About PharmaKrysto PharmaKrysto focuses on research and development, with a specific focus on Cystinuria. The company is primarily engaged in the development of new treatments for โ€ฆSee details»

Scottish biopharma start-up in rare kidney disease deal

Jul 12, 2018 A Borders-based drug development start-up has signed a licensing deal with a US university after its potential new treatment for a rare type of inherited kidney disease cleared โ€ฆSee details»

PHARMAKRYSTO EBT TRUSTEE LIMITED - Companies House

PHARMAKRYSTO EBT TRUSTEE LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, โ€ฆSee details»

Company Information & Financial Data Pharmakrysto Ltd - 192.com

Company information for Pharmakrysto Ltd, including company directors, annual reports, significant shareholders, registered office address, financial data and more. Registration โ€ฆSee details»

PharmaKrysto - Drug pipelines, Patents, Clinical trials - Synapse

Explore PharmaKrysto with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Endocrinology and Metabolic Disease, Technology Platform:Small ...See details»

Pharmakrysto Ltd. net worth, address, company information. Free

Free information packet about Pharmakrysto Ltd: maps, contact data, PSC (persons with significant control), incorporation date, financials and filings. Convenient access to tables and โ€ฆSee details»

PharmaKrysto - Technology Opportunities & Ventures by NYU and โ€ฆ

PharmaKrysto was established to address the issue of pain and kidney damage caused by cystine crystal-stones in people with Cystinuria. Their team has collaborated with scientists to โ€ฆSee details»

Scottish start-up PharmaKrysto signs licensing agreement with US ...

Jul 13, 2018 A SCOTTISH biopharmaceutical start-up has signed a global licensing deal with an American university after its new treatment for the kidney diseaseโ€ฆSee details»

Scottish biopharma start-up in rare kidney disease deal

Jul 12, 2018 New treatment now also granted Orphan Designation in the US and EU PharmaKrysto Ltd, a biopharmaceutical company based in Scotland, UK, announces today โ€ฆSee details»

PharmaKrysto Announce Global Deal - Spreng Thomson

Jul 12, 2018 PharmaKrysto Ltd, a biopharmaceutical company based in Scotland, UK, announces today that it has completed an exclusive global licensing deal with Rutgers โ€ฆSee details»